{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:54:51Z","timestamp":1790434491684,"version":"4.1.0"},"reference-count":285,"publisher":"Elsevier","isbn-type":[{"value":"9780128104873","type":"print"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/bs.ctdb.2018.11.020","type":"book-chapter","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T22:02:44Z","timestamp":1546552964000},"page":"195-234","source":"Crossref","is-referenced-by-count":61,"title":["Fibroblast growth factors in skeletal development"],"prefix":"10.1016","author":[{"given":"David M.","family":"Ornitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre J.","family":"Marie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.ctdb.2018.11.020_bb0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jcp.21170","article-title":"Anti-apoptotic Bcl-2 enhancing requires FGF-2\/FGF receptor 1 binding in mouse osteoblasts","volume":"214","author":"Agas","year":"2008","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0015","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1002\/jcp.24382","article-title":"FGF-2 enhances Runx-2\/Smads nuclear localization in BMP-2 canonical signaling in osteoblasts","volume":"228","author":"Agas","year":"2013","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0020","doi-asserted-by":"crossref","first-page":"29347","DOI":"10.1074\/jbc.M101859200","article-title":"Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2","volume":"276","author":"Aikawa","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0025","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1128\/MCB.01849-07","article-title":"Fibroblast growth factor signaling uses multiple mechanisms to inhibit Wnt-induced transcription in osteoblasts","volume":"28","author":"Ambrosetti","year":"2008","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bone.2017.08.016","article-title":"ARQ 087 inhibits FGFR signaling and rescues aberrant cell proliferation and differentiation in experimental models of craniosynostoses and chondrodysplasias caused by activating mutations in FGFR1, FGFR2 and FGFR3","volume":"105","author":"Balek","year":"2017","journal-title":"Bone"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0035","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/jcp.20148","article-title":"P253R fibroblast growth factor receptor-2 mutation induces RUNX2 transcript variants and calvarial osteoblast differentiation","volume":"202","author":"Baroni","year":"2005","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.berh.2007.12.008","article-title":"Achondroplasia","volume":"22","author":"Baujat","year":"2008","journal-title":"Best Practice & Research. Clinical Rheumatology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0045","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2052.2005.01398.x","article-title":"A single-base change in the tyrosine kinase II domain of ovine FGFR3 causes hereditary chondrodysplasia in sheep","volume":"37","author":"Beever","year":"2006","journal-title":"Animal Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1096-8628(19990702)85:1<53::AID-AJMG10>3.0.CO;2-F","article-title":"Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): Phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3","volume":"85","author":"Bellus","year":"1999","journal-title":"American Journal of Medical Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0055","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng0795-357","article-title":"A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia","volume":"10","author":"Bellus","year":"1995","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0060","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/316892","article-title":"Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype","volume":"67","author":"Bellus","year":"2000","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a015958","article-title":"Molecular mechanisms of fibroblast growth factor signaling in physiology and pathology","volume":"5","author":"Belov","year":"2013","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0070","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001339","article-title":"Vertebrate limb development: Moving from classical morphogen gradients to an integrated 4-dimensional patterning system","volume":"1","author":"Benazet","year":"2009","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0075","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/(SICI)1096-8628(19960503)63:1<148::AID-AJMG26>3.0.CO;2-N","article-title":"Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism","volume":"63","author":"Bonaventure","year":"1996","journal-title":"American Journal of Medical Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0080","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1101\/gad.277137.115","article-title":"Genetic insights into the mechanisms of Fgf signaling","volume":"30","author":"Brewer","year":"2016","journal-title":"Genes & Development"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0085","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1097\/00006534-200112000-00030","article-title":"From genotype to phenotype: The differential expression of FGF, FGFR, and TGFbeta genes characterizes human cranioskeletal development and reflects clinical presentation in FGFR syndromes","volume":"108","author":"Britto","year":"2001","journal-title":"Plastic and Reconstructive Surgery"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0090","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/(SICI)1096-8628(19990611)84:5<476::AID-AJMG12>3.0.CO;2-X","article-title":"Platyspondylic lethal skeletal dysplasia, San Diego type, is caused by FGFR3 mutations","volume":"84","author":"Brodie","year":"1999","journal-title":"American Journal of Medical Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0095","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1016\/j.febslet.2010.09.048","article-title":"Grb14 inhibits FGF receptor signaling through the regulation of PLCgamma recruitment and activation","volume":"584","author":"Browaeys-Poly","year":"2010","journal-title":"FEBS Letters"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0100","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.bbadis.2014.12.020","article-title":"Fibroblast growth factor and canonical WNT\/beta-catenin signaling cooperate in suppression of chondrocyte differentiation in experimental models of FGFR signaling in cartilage","volume":"1852","author":"Buchtova","year":"2015","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0105","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1126\/science.280.5367.1262","article-title":"Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase","volume":"280","author":"Camps","year":"1998","journal-title":"Science"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/12615","article-title":"Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas","volume":"23","author":"Cappellen","year":"1999","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0115","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/ajmg.a.38839","article-title":"Novel phenotype of achondroplasia due to biallelic FGFR3 pathogenic variants","volume":"176","author":"Chang","year":"2018","journal-title":"American Journal of Medical Genetics. Part A"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0120","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1074\/mcp.M116.064980","article-title":"Phosphoproteomics of fibroblast growth factor 1 (FGF1) signaling in chondrocytes: Identifying the signature of inhibitory response","volume":"16","author":"Chapman","year":"2017","journal-title":"Molecular & Cellular Proteomics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0125","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1172\/JCI6690","article-title":"Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis","volume":"104","author":"Chen","year":"1999","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0130","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/jbmr.1871","article-title":"Compensatory regulation of the Snai1 and Snai2 genes during chondrogenesis","volume":"28","author":"Chen","year":"2013","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0135","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S8756-3282(03)00222-9","article-title":"A Ser252Trp [corrected] substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis","volume":"33","author":"Chen","year":"2003","journal-title":"Bone"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0140","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/hmg\/10.5.457","article-title":"A Ser(365)\u2192Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh\/PTHrP signals and causes severe achondroplasia","volume":"10","author":"Chen","year":"2001","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0145","article-title":"A Ser252Trp mutation in fibroblast growth factor receptor 2 (FGFR2) mimicking human Apert syndrome reveals an essential role for FGF signaling in the regulation of endochondral bone formation","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0150","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/ng0797-260","article-title":"Frequent translocation t(4,14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3","volume":"16","author":"Chesi","year":"1997","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0155","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1089\/scd.2007.0230","article-title":"Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1\/2 signaling pathways","volume":"17","author":"Choi","year":"2008","journal-title":"Stem Cells and Development"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0160","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/dvdy.20323","article-title":"Runx2 regulates FGF2-induced Bmp2 expression during cranial bone development","volume":"233","author":"Choi","year":"2005","journal-title":"Developmental Dynamics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0165","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s40610-016-0035-5","article-title":"Systemic control of bone homeostasis by FGF23 signaling","volume":"2","author":"Clinkenbeard","year":"2016","journal-title":"Current Molecular Biology Reports"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0170","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1101\/gad.10.13.1633","article-title":"Shared role of the pRB-related p130 and p107 proteins in limb development","volume":"10","author":"Cobrinik","year":"1996","journal-title":"Genes & Development"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0175","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ng0496-390","article-title":"Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3","volume":"12","author":"Colvin","year":"1996","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0180","doi-asserted-by":"crossref","first-page":"6801","DOI":"10.1182\/blood-2010-12-321539","article-title":"Inhibition of cellular senescence by developmentally regulated FGF receptors in mesenchymal stem cells","volume":"117","author":"Coutu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0185","doi-asserted-by":"crossref","first-page":"32005","DOI":"10.1074\/jbc.M304698200","article-title":"Age-related changes in the biomolecular mechanisms of calvarial osteoblast biology affect fibroblast growth factor-2 signaling and osteogenesis","volume":"278","author":"Cowan","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0190","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cytogfr.2005.01.007","article-title":"Mechanisms underlying differential responses to FGF signaling","volume":"16","author":"Dailey","year":"2005","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0195","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1083\/jcb.200302075","article-title":"A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation","volume":"161","author":"Dailey","year":"2003","journal-title":"The Journal of Cell Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0200","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.devcel.2007.09.016","article-title":"Snail1 is a transcriptional effector of FGFR3 signaling during chondrogenesis and achondroplasias","volume":"13","author":"de Frutos","year":"2007","journal-title":"Developmental Cell"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0205","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/ajmg.a.36504","article-title":"Homozygous N540K hypochondroplasia\u2014First report: Radiological and clinical features","volume":"164a","author":"De Rosa","year":"2014","journal-title":"American Journal of Medical Genetics. Part A"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0210","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1359\/jbmr.1998.13.4.645","article-title":"The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific","volume":"13","author":"Debiais","year":"1998","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0215","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0925-4773(98)00133-6","article-title":"Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification","volume":"77","author":"Delezoide","year":"1998","journal-title":"Mechanisms of Development"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0220","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0092-8674(00)81069-7","article-title":"Fibroblast growth factor receptor 3 is a negative regulator of bone growth","volume":"84","author":"Deng","year":"1996","journal-title":"Cell"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0225","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1093\/hmg\/ddu004","article-title":"FGFR3 mutation causes abnormal membranous ossification in achondroplasia","volume":"23","author":"Di Rocco","year":"2014","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0230","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1006367032156","article-title":"Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: Implications for combination treatment with photodynamic therapy","volume":"17","author":"Dimitroff","year":"1999","journal-title":"Investigational New Drugs"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0235","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.bone.2008.02.009","article-title":"FGFR2-Cbl interaction in lipid rafts triggers attenuation of PI3K\/Akt signaling and osteoblast survival","volume":"42","author":"Dufour","year":"2008","journal-title":"Bone"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0240","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1002\/ajmg.a.37676","article-title":"A second family with CATSHL syndrome: Confirmatory report of another unique FGFR3 syndrome","volume":"170","author":"Escobar","year":"2016","journal-title":"American Journal of Medical Genetics. Part A"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0245","doi-asserted-by":"crossref","first-page":"12555","DOI":"10.1073\/pnas.0405031101","article-title":"A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis","volume":"101","author":"Eswarakumar","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0250","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cytogfr.2005.01.001","article-title":"Cellular signaling by fibroblast growth factor receptors","volume":"16","author":"Eswarakumar","year":"2005","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0255","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1242\/dev.129.16.3783","article-title":"The IIIc alternative of Fgfr2 is a positive regulator of bone formation","volume":"129","author":"Eswarakumar","year":"2002","journal-title":"Development"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0260","doi-asserted-by":"crossref","first-page":"18603","DOI":"10.1073\/pnas.0609157103","article-title":"Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis","volume":"103","author":"Eswarakumar","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0265","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1073\/pnas.0700012104","article-title":"Skeletal overgrowth is mediated by deficiency in a specific isoform of fibroblast growth factor receptor 3","volume":"104","author":"Eswarakumar","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0270","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bone.2004.10.003","article-title":"Effects of FGF-2\/-9 in calvarial bone cell cultures: Differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential","volume":"36","author":"Fakhry","year":"2005","journal-title":"Bone"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0275","doi-asserted-by":"crossref","first-page":"40575","DOI":"10.1074\/jbc.M111.274910","article-title":"Fibroblast growth factor 2 stimulation of osteoblast differentiation and bone formation is mediated by modulation of the Wnt signaling pathway","volume":"286","author":"Fei","year":"2011","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0280","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.2174\/1381612043383773","article-title":"Growth factors and bone formation in osteoporosis: Roles for fibroblast growth factor and transforming growth factor beta","volume":"10","author":"Fromigue","year":"2004","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0285","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.molcel.2006.01.022","article-title":"Autophosphorylation of FGFR1 kinase is mediated by a sequential and precisely ordered reaction","volume":"21","author":"Furdui","year":"2006","journal-title":"Molecular Cell"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0290","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006247","article-title":"Postnatal soluble FGFR3 therapy rescues achondroplasia symptoms and restores bone growth in mice","volume":"5","author":"Garcia","year":"2013","journal-title":"Science Translational Medicine"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0295","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1359\/jbmr.1999.14.11.1909","article-title":"Skeletal dysplasia and defective chondrocyte differentiation by targeted overexpression of fibroblast growth factor 9 in transgenic mice","volume":"14","author":"Garofalo","year":"1999","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0300","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1210\/endo-123-1-98","article-title":"Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor beta","volume":"123","author":"Globus","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0305","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nrm3528","article-title":"Exploring mechanisms of FGF signalling through the lens of structural biology","volume":"14","author":"Goetz","year":"2013","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0310","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/hyb.2009.0018","article-title":"Generation of monoclonal antibody targeting fibroblast growth factor receptor 3","volume":"28","author":"Gorbenko","year":"2009","journal-title":"Hybridoma (Larchmt)"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0315","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1073\/pnas.89.8.3271","article-title":"Syndecan 3: A member of the syndecan family of membrane-intercalated proteoglycans that is expressed in high amounts at the onset of chicken limb cartilage differentiation","volume":"89","author":"Gould","year":"1992","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0320","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/hmg\/ddv441","article-title":"Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short-stature syndromes","volume":"25","author":"Gudernova","year":"2016","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0325","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/hmg\/ddi152","article-title":"A role for fibroblast growth factor receptor-2 in the altered osteoblast phenotype induced by Twist haploinsufficiency in the Saethre-Chotzen syndrome","volume":"14","author":"Guenou","year":"2005","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0330","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1158\/1535-7163.MCT-12-1150","article-title":"Fibroblast growth factor receptor 3 is a rational therapeutic target in bladder cancer","volume":"12","author":"Gust","year":"2013","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0335","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1172\/JCI38948","article-title":"FGFR3-targeted mAb therapy for bladder cancer and multiple myeloma","volume":"119","author":"Hadari","year":"2009","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0340","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000115037","article-title":"Fibroblast growth factor signaling in cranial suture development and pathogenesis","volume":"12","author":"Hajihosseini","year":"2008","journal-title":"Frontiers of Oral Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0345","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s007740050095","article-title":"Immunohistochemical localization of fibroblast growth factor receptors in the rat mandibular condylar cartilage and tibial cartilage","volume":"17","author":"Hamada","year":"1999","journal-title":"Journal of Bone and Mineral Metabolism"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0350","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/jcp.22152","article-title":"Autocrine fibroblast growth factor 18 mediates dexamethasone-induced osteogenic differentiation of murine mesenchymal stem cells","volume":"224","author":"Hamidouche","year":"2010","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0355","doi-asserted-by":"crossref","first-page":"10447","DOI":"10.1074\/jbc.M114.609230","article-title":"Membrane and integrative nuclear fibroblastic growth factor receptor (FGFR) regulation of FGF-23","volume":"290","author":"Han","year":"2015","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0360","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/ncb867","article-title":"Sprouty1 and Sprouty2 provide a control mechanism for the Ras\/MAPK signalling pathway","volume":"4","author":"Hanafusa","year":"2002","journal-title":"Nature Cell Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0365","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/jcp.21825","article-title":"The heparan sulfate proteoglycan (HSPG) glypican-3 mediates commitment of MC3T3-E1 cells toward osteogenesis","volume":"220","author":"Haupt","year":"2009","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0370","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ydbio.2008.01.035","article-title":"Roles of FGFR3 during morphogenesis of Meckel's cartilage and mandibular bones","volume":"316","author":"Havens","year":"2008","journal-title":"Developmental Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0375","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bone.2014.03.003","article-title":"Morphological comparison of the craniofacial phenotypes of mouse models expressing the Apert FGFR2 S252W mutation in neural crest- or mesoderm-derived tissues","volume":"63","author":"Heuze","year":"2014","journal-title":"Bone"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0380","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1101\/gad.1482906","article-title":"Runx2 inhibits chondrocyte proliferation and hypertrophy through its expression in the perichondrium","volume":"20","author":"Hinoi","year":"2006","journal-title":"Genes & Development"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0385","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ydbio.2009.01.026","article-title":"Early onset of craniosynostosis in an Apert mouse model reveals critical features of this pathology","volume":"328","author":"Holmes","year":"2009","journal-title":"Developmental Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201492","article-title":"C-type natriuretic peptide analog treatment of craniosynostosis in a Crouzon syndrome mouse model","volume":"13","author":"Holmes","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0395","doi-asserted-by":"crossref","first-page":"36303","DOI":"10.1074\/jbc.M114.619569","article-title":"Knockout of nuclear high molecular weight FGF2 isoforms in mice modulates bone and phosphate homeostasis","volume":"289","author":"Homer-Bouthiette","year":"2014","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0400","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(07)61090-3","article-title":"Achondroplasia","volume":"370","author":"Horton","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0405","doi-asserted-by":"crossref","first-page":"H2167","DOI":"10.1152\/ajpheart.00392.2005","article-title":"Cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2 is mediated by the MAPK cascade","volume":"289","author":"House","year":"2005","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0410","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ydbio.2016.01.008","article-title":"A combined series of Fgf9 and Fgf18 mutant alleles identifies unique and redundant roles in skeletal development","volume":"411","author":"Hung","year":"2016","journal-title":"Developmental Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0415","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ydbio.2007.04.048","article-title":"FGF9 regulates early hypertrophic chondrocyte differentiation and skeletal vascularization in the developing stylopod","volume":"307","author":"Hung","year":"2007","journal-title":"Developmental Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0420","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1359\/jbmr.1999.14.5.776","article-title":"Parathyroid hormone regulates the expression of fibroblast growth factor-2 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells","volume":"14","author":"Hurley","year":"1999","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0425","first-page":"5","article-title":"Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome","volume":"5","author":"Ibrahimi","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0430","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1359\/jbmr.2003.18.4.751","article-title":"Fibroblast growth factors lead to increased Msx2 expression and fusion in calvarial sutures","volume":"18","author":"Ignelzi","year":"2003","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0435","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1002\/jcp.26345","article-title":"FGF-2 promotes osteocyte differentiation through increased E11\/podoplanin expression","volume":"233","author":"Ikpegbu","year":"2018","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0440","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/hmg\/9.11.1603","article-title":"A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos","volume":"9","author":"Iwata","year":"2000","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0445","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/hmg\/10.12.1255","article-title":"Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice","volume":"10","author":"Iwata","year":"2001","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0450","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jcp.20813","article-title":"Heparan sulfate regulates the anabolic activity of MC3T3-E1 preosteoblast cells by induction of Runx2","volume":"210","author":"Jackson","year":"2007","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0455","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ydbio.2006.05.031","article-title":"Fibroblast growth factor receptor 1 signaling in the osteo-chondrogenic cell lineage regulates sequential steps of osteoblast maturation","volume":"296","author":"Jacob","year":"2006","journal-title":"Developmental Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0460","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/77eec9d5-379f-4895-8b85-308ee29facf4","article-title":"Investigating the role of FGF18 in the cultivation and osteogenic differentiation of mesenchymal stem cells","volume":"7","author":"Jeon","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0465","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ejhg.2010.235","article-title":"Craniosynostosis","volume":"19","author":"Johnson","year":"2011","journal-title":"European Journal of Human Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0470","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/hmg\/ddr514","article-title":"A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain-of-function Fgfr3 mouse model","volume":"21","author":"Jonquoy","year":"2012","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0475","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1242\/jcs.01679","article-title":"Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation","volume":"118","author":"Kaabeche","year":"2005","journal-title":"Journal of Cell Science"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0480","doi-asserted-by":"crossref","first-page":"36259","DOI":"10.1074\/jbc.M402469200","article-title":"Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation","volume":"279","author":"Kaabeche","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0485","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012228","article-title":"bFGF regulates PI3-kinase-Rac1-JNK pathway and promotes fibroblast migration in wound healing","volume":"5","author":"Kanazawa","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0490","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1530\/EJE-14-0945","article-title":"A novel variant of FGFR3 causes proportionate short stature","volume":"172","author":"Kant","year":"2015","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0495","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1093\/hmg\/ddv019","article-title":"FGFR1 signaling in hypertrophic chondrocytes is attenuated by the Ras-GAP neurofibromin during endochondral bone formation","volume":"24","author":"Karolak","year":"2015","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0500","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1242\/dev.131722","article-title":"FGF signaling in the osteoprogenitor lineage non-autonomously regulates postnatal chondrocyte proliferation and skeletal growth","volume":"143","author":"Karuppaiah","year":"2016","journal-title":"Development"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0505","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1074\/jbc.M203750200","article-title":"The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2","volume":"278","author":"Kim","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0510","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1242\/dev.125.7.1241","article-title":"FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development","volume":"125","author":"Kim","year":"1998","journal-title":"Development"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0515","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1128\/MCB.01730-12","article-title":"The B55alpha regulatory subunit of protein phosphatase 2A mediates fibroblast growth factor-induced p107 dephosphorylation and growth arrest in chondrocytes","volume":"33","author":"Kolupaeva","year":"2013","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0520","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003447","article-title":"PP2A-mediated dephosphorylation of p107 plays a critical role in chondrocyte cell cycle arrest by FGF","volume":"3","author":"Kolupaeva","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0525","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1172\/JCI83926","article-title":"Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse model","volume":"126","author":"Komla-Ebri","year":"2016","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0530","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0092-8674(00)80252-4","article-title":"A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras\/MAPK signaling pathway","volume":"89","author":"Kouhara","year":"1997","journal-title":"Cell"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035826","article-title":"Receptor tyrosine kinases activate canonical WNT\/beta-catenin signaling via MAP kinase\/LRP6 pathway and direct beta-catenin phosphorylation","volume":"7","author":"Krejci","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0540","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1242\/jcs.017160","article-title":"STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes","volume":"121","author":"Krejci","year":"2008","journal-title":"Journal of Cell Science"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003961","article-title":"Analysis of STAT1 activation by six FGFR3 mutants associated with skeletal dysplasia undermines dominant role of STAT1 in FGFR3 signaling in cartilage","volume":"3","author":"Krejci","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0550","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/gerona\/glt018","article-title":"Fibroblast growth factor-2 and bone morphogenetic protein-2 have a synergistic stimulatory effect on bone formation in cell cultures from elderly mouse and human bone","volume":"68","author":"Kuhn","year":"2013","journal-title":"The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0555","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.celrep.2014.07.038","article-title":"Fibroblast growth factor maintains chondrogenic potential of limb bud mesenchymal cells by modulating DNMT3A recruitment","volume":"8","author":"Kumar","year":"2014","journal-title":"Cell Reports"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0560","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/hmg\/ddy031","article-title":"Regulation of ciliary function by fibroblast growth factor signaling identifies FGFR3-related disorders achondroplasia and thanatophoric dysplasia as ciliopathies","volume":"27","author":"Kunova Bosakova","year":"2018","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0565","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1128\/MCB.00082-13","article-title":"Activation of p107 by fibroblast growth factor, which is essential for chondrocyte cell cycle exit, is mediated by the protein phosphatase 2A\/B55alpha holoenzyme","volume":"33","author":"Kurimchak","year":"2013","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0570","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00774-011-0288-2","article-title":"FGF and ERK signaling coordinately regulate mineralization-related genes and play essential roles in osteocyte differentiation","volume":"30","author":"Kyono","year":"2012","journal-title":"Journal of Bone and Mineral Metabolism"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0575","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1128\/MCB.24.13.5657-5666.2004","article-title":"The docking protein Gab1 is an essential component of an indirect mechanism for fibroblast growth factor stimulation of the phosphatidylinositol 3-kinase\/Akt antiapoptotic pathway","volume":"24","author":"Lamothe","year":"2004","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0580","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1083\/jcb.200205025","article-title":"FGF signaling targets the pRb-related p107 and p130 proteins to induce chondrocyte growth arrest","volume":"158","author":"Laplantine","year":"2002","journal-title":"The Journal of Cell Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0585","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bone.2006.10.013","article-title":"Fibroblast growth factor expression in the postnatal growth plate","volume":"40","author":"Lazarus","year":"2007","journal-title":"Bone"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0590","doi-asserted-by":"crossref","first-page":"43220","DOI":"10.1038\/srep43220","article-title":"Knock-in human FGFR3 achondroplasia mutation as a mouse model for human skeletal dysplasia","volume":"7","author":"Lee","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0595","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bone.2003.09.002","article-title":"Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias","volume":"34","author":"Legeai-Mallet","year":"2004","journal-title":"Bone"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0600","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"Lemmon","year":"2010","journal-title":"Cell"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0605","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0002-9440(10)64139-9","article-title":"Increased osteoblast apoptosis in apert craniosynostosis: Role of protein kinase C and interleukin-1","volume":"158","author":"Lemonnier","year":"2001","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0610","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1359\/jbmr.2001.16.5.832","article-title":"Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis","volume":"16","author":"Lemonnier","year":"2001","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0615","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/hmg\/8.1.35","article-title":"A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors","volume":"8","author":"Li","year":"1999","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0620","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jmicro\/dfq002","article-title":"FGFR3 down-regulates PTH\/PTHrP receptor gene expression by mediating JAK\/STAT signaling in chondrocytic cell line","volume":"59","author":"Li","year":"2010","journal-title":"Journal of Electron Microscopy"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0625","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.yjmcc.2006.10.005","article-title":"The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: The role of JNK signaling","volume":"42","author":"Liao","year":"2007","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0630","doi-asserted-by":"crossref","first-page":"37419","DOI":"10.1074\/jbc.M304544200","article-title":"Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX","volume":"278","author":"Liu","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0635","first-page":"292506","article-title":"Craniosynostosis-associated Fgfr2(C342Y) mutant bone marrow stromal cells exhibit cell autonomous abnormalities in osteoblast differentiation and bone formation","volume":"2013","author":"Liu","year":"2013","journal-title":"BioMed Research International"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0640","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ydbio.2006.08.071","article-title":"FGF18 is required for early chondrocyte proliferation, hypertrophy and vascular invasion of the growth plate","volume":"302","author":"Liu","year":"2007","journal-title":"Developmental Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0645","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00223-013-9701-2","article-title":"Further analysis of the Crouzon mouse: Effects of the FGFR2(C342Y) mutation are cranial bone-dependent","volume":"92","author":"Liu","year":"2013","journal-title":"Calcified Tissue International"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0650","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1101\/gad.965602","article-title":"Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18","volume":"16","author":"Liu","year":"2002","journal-title":"Genes & Development"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0655","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1152\/ajpendo.00008.2006","article-title":"Pathogenic role of Fgf23 in Hyp mice","volume":"291","author":"Liu","year":"2006","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0660","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1359\/jbmr.2001.16.4.705","article-title":"Increased expression of protein kinase C alpha, interleukin-1 alpha, and RhoA guanosine 5 \u2018-triphosphatase in osteoblasts expressing the Ser252Trp fibroblast growth factor 2 Apert mutation: Identification by analysis of complementary DNA microarray","volume":"16","author":"Lomri","year":"2001","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0665","first-page":"1310","article-title":"Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome","volume":"101","author":"Lomri","year":"1998","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0670","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ajhg.2012.10.014","article-title":"Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating Achondroplasia","volume":"91","author":"Lorget","year":"2012","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0675","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/humu.22597","article-title":"A novel homozygous mutation in FGFR3 causes tall stature, severe lateral tibial deviation, scoliosis, hearing impairment, camptodactyly, and arachnodactyly","volume":"35","author":"Makrythanasis","year":"2014","journal-title":"Human Mutation"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0680","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/bonekey.2015.33","article-title":"Role of syndecan-2 in osteoblast biology and pathology","volume":"4","author":"Mansouri","year":"2015","journal-title":"BoneKEy Reports"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0685","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1083\/jcb.200409182","article-title":"Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation","volume":"168","author":"Mansukhani","year":"2005","journal-title":"The Journal of Cell Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0690","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1083\/jcb.149.6.1297","article-title":"Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts","volume":"149","author":"Mansukhani","year":"2000","journal-title":"The Journal of Cell Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0695","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nature06876","article-title":"Genetic evidence that FGFs have an instructive role in limb proximal-distal patterning","volume":"453","author":"Mariani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0700","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2012.01.086","article-title":"Fibroblast growth factor signaling controlling bone formation: An update","volume":"498","author":"Marie","year":"2012","journal-title":"Gene"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0705","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s00018-014-1801-2","article-title":"Osteoblast dysfunctions in bone diseases: From cellular and molecular mechanisms to therapeutic strategies","volume":"72","author":"Marie","year":"2015","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0710","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/jcb.20582","article-title":"FGF and FGFR signaling in chondrodysplasias and craniosynostosis","volume":"96","author":"Marie","year":"2005","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0715","first-page":"877","article-title":"Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling","volume":"17","author":"Marie","year":"2002","journal-title":"Histology and Histopathology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0720","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000115036","article-title":"Roles of FGFR2 and twist in human craniosynostosis: Insights from genetic mutations in cranial osteoblasts","volume":"12","author":"Marie","year":"2008","journal-title":"Frontiers of Oral Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0725","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1101\/gad.12.11.1571","article-title":"The roles of FGFs in the early development of vertebrate limbs","volume":"12","author":"Martin","year":"1998","journal-title":"Genes & Development"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0730","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1096\/fj.10-177816","article-title":"Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling","volume":"25","author":"Martin","year":"2011","journal-title":"The FASEB Journal"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0735","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1158\/1078-0432.CCR-05-0282","article-title":"Targeting the extracellular domain of fibroblast growth factor receptor 3 with human single-chain Fv antibodies inhibits bladder carcinoma cell line proliferation","volume":"11","author":"Martinez-Torrecuadrada","year":"2005","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0740","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/hmg\/ddn339","article-title":"FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway","volume":"18","author":"Matsushita","year":"2009","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0745","doi-asserted-by":"crossref","first-page":"6924","DOI":"10.1074\/jbc.M512932200","article-title":"Inhibition or activation of Apert syndrome FGFR2 (S252W) signaling by specific glycosaminoglycans","volume":"281","author":"McDowell","year":"2006","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0750","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1002\/ajmg.a.33703","article-title":"Genetic basis of potential therapeutic strategies for craniosynostosis","volume":"152A","author":"Melville","year":"2010","journal-title":"American Journal of Medical Genetics. Part A"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0755","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ajhg.2012.02.005","article-title":"Bent bone dysplasia-FGFR2 type, a distinct skeletal disorder, has deficient canonical FGF signaling","volume":"90","author":"Merrill","year":"2012","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0760","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.3146re9","article-title":"Fibroblast growth factor receptor signaling crosstalk in skeletogenesis","volume":"3","author":"Miraoui","year":"2010","journal-title":"Science Signaling"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0765","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1074\/jbc.M805432200","article-title":"Fibroblast growth factor receptor 2 promotes osteogenic differentiation in mesenchymal cells via ERK1\/2 and protein kinase C signaling","volume":"284","author":"Miraoui","year":"2009","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0770","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/hmg\/ddq045","article-title":"Increased EFG- and PDGFalpha-receptor signaling by mutant FGF-receptor 2 contributes to osteoblast dysfunction in Apert craniosynostosis","volume":"19","author":"Miraoui","year":"2010","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0775","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/jcb.22628","article-title":"Molecular silencing of Twist1 enhances osteogenic differentiation of murine mesenchymal stem cells: Implication of FGFR2 signaling","volume":"110","author":"Miraoui","year":"2010","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0780","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1128\/MCB.00885-08","article-title":"Sustained platelet-derived growth factor receptor alpha signaling in osteoblasts results in craniosynostosis by overactivating the phospholipase C-gamma pathway","volume":"29","author":"Moenning","year":"2009","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0785","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1126\/science.276.5314.955","article-title":"Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors","volume":"276","author":"Mohammadi","year":"1997","journal-title":"Science"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0790","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s004410051258","article-title":"Alterations of matrix- and cell-associated proteoglycans inhibit osteogenesis and growth response to fibroblast growth factor-2 in cultured rat mandibular condyle and calvaria","volume":"295","author":"Molteni","year":"1999","journal-title":"Cell and Tissue Research"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0795","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S8756-3282(98)00191-4","article-title":"Differential expression of fibroblast growth factor receptor-1, -2, and -3 and syndecan-1, -2, and -4 in neonatal rat mandibular condyle and calvaria during osteogenic differentiation in vitro","volume":"24","author":"Molteni","year":"1999","journal-title":"Bone"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0800","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1172\/JCI8641","article-title":"Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation","volume":"105","author":"Montero","year":"2000","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0805","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biocel.2017.12.008","article-title":"Mutant FGFR3 associated with SADDAN disease causes cytoskeleton disorganization through PLCgamma1\/Src-mediated paxillin hyperphosphorylation","volume":"95","author":"Montone","year":"2018","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0810","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/dvdy.24099","article-title":"Soluble form of FGFR2 with S252W partially prevents craniosynostosis of the apert mouse model","volume":"243","author":"Morita","year":"2014","journal-title":"Developmental Dynamics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0815","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-213X-14-8","article-title":"Craniofacial divergence by distinct prenatal growth patterns in Fgfr2 mutant mice","volume":"14","author":"Motch Perrine","year":"2014","journal-title":"BMC Developmental Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0820","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1093\/hmg\/dds065","article-title":"An activating Fgfr3 mutation affects trabecular bone formation via a paracrine mechanism during growth","volume":"21","author":"Mugniery","year":"2012","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0825","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1101\/gad.1179104","article-title":"Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype","volume":"18","author":"Murakami","year":"2004","journal-title":"Genes & Development"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0830","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1073\/pnas.97.3.1113","article-title":"Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway","volume":"97","author":"Murakami","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0835","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1469-1809.1970.tb01648.x","article-title":"Achondroplasia\u2014a genetic and statistical survey","volume":"33","author":"Murdoch","year":"1970","journal-title":"Annals of Human Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0840","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1002\/jcb.21589","article-title":"Reduced expression and function of bone morphogenetic protein-2 in bones of Fgf2 null mice","volume":"103","author":"Naganawa","year":"2008","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0845","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bone.2004.11.010","article-title":"Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice","volume":"36","author":"Nakamura","year":"2005","journal-title":"Bone"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0850","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1242\/dev.125.24.4977","article-title":"Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3","volume":"125","author":"Naski","year":"1998","journal-title":"Development"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0855","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ng0696-233","article-title":"Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia","volume":"13","author":"Naski","year":"1996","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0860","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1093\/hmg\/ddu282","article-title":"Bent bone dysplasia syndrome reveals nucleolar activity for FGFR2 in ribosomal DNA transcription","volume":"23","author":"Neben","year":"2014","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0865","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/bs.ctdb.2015.09.005","article-title":"Signaling pathways in craniofacial development: Insights from rare skeletal disorders","volume":"115","author":"Neben","year":"2015","journal-title":"Current Topics in Developmental Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0870","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1093\/hmg\/ddx209","article-title":"FGFR2 mutations in bent bone dysplasia syndrome activate nucleolar stress and perturb cell fate determination","volume":"26","author":"Neben","year":"2017","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0875","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.1867","article-title":"The regulation of runt-related transcription factor 2 by fibroblast growth factor-2 and connexin43 requires the inositol polyphosphate\/protein kinase Cdelta cascade","volume":"28","author":"Niger","year":"2013","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0880","doi-asserted-by":"crossref","first-page":"8219","DOI":"10.1074\/jbc.M307304200","article-title":"Distinctive expression patterns of heparan sulfate O-sulfotransferases and regional differences in heparan sulfate structure in chick limb buds","volume":"279","author":"Nogami","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0885","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107577","article-title":"SOX9 regulates multiple genes in chondrocytes, including genes encoding ECM proteins, ECM modification enzymes, receptors, and transporters","volume":"9","author":"Oh","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0890","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1101\/gad.965702","article-title":"FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis","volume":"16","author":"Ohbayashi","year":"2002","journal-title":"Genes & Development"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0895","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M","article-title":"FGFs, heparan sulfate and FGFRs: Complex interactions essential for development","volume":"22","author":"Ornitz","year":"2000","journal-title":"BioEssays"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0900","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/wdev.176","article-title":"The fibroblast growth factor signaling pathway","volume":"4","author":"Ornitz","year":"2015","journal-title":"Wiley Interdisciplinary Reviews: Developmental Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0905","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/dvdy.24479","article-title":"Achondroplasia: Development, pathogenesis, and therapy","volume":"246","author":"Ornitz","year":"2017","journal-title":"Developmental Dynamics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0910","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1101\/gad.990702","article-title":"FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease","volume":"16","author":"Ornitz","year":"2002","journal-title":"Genes & Development"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0915","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1101\/gad.266551.115","article-title":"Fibroblast growth factor signaling in skeletal development and disease","volume":"29","author":"Ornitz","year":"2015","journal-title":"Genes & Development"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0920","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1242\/dev.113.4.1419","article-title":"Developmental expression of two murine fibroblast growth factor receptors, flg and bek","volume":"113","author":"Orr-Urtreger","year":"1991","journal-title":"Development"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0925","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbadis.2008.11.010","article-title":"Activating Fgfr3 Y367C mutation causes hearing loss and inner ear defect in a mouse model of chondrodysplasia","volume":"1792","author":"Pannier","year":"2009","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0930","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1074\/jbc.M109.055053","article-title":"FGF2-activated ERK mitogen-activated protein kinase enhances Runx2 acetylation and stabilization","volume":"285","author":"Park","year":"2010","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0935","doi-asserted-by":"crossref","first-page":"24252","DOI":"10.18632\/oncotarget.8132","article-title":"Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use","volume":"7","author":"Patani","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0940","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1148\/radiology.196.2.7617874","article-title":"Homozygous achondroplasia: US distinction between homozygous, heterozygous, and unaffected fetuses in the second trimester","volume":"196","author":"Patel","year":"1995","journal-title":"Radiology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0945","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ajmg.1320160404","article-title":"Homozygous achondroplasia with survival beyond infancy","volume":"16","author":"Pauli","year":"1983","journal-title":"American Journal of Medical Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0950","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1227\/01.NEU.0000224323.53866.1E","article-title":"A model for the pharmacological treatment of crouzon syndrome","volume":"59","author":"Perlyn","year":"2006","journal-title":"Neurosurgery"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0955","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/dbio.1993.1040","article-title":"Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis","volume":"155","author":"Peters","year":"1993","journal-title":"Developmental Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0960","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1242\/dev.114.1.233","article-title":"Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse","volume":"114","author":"Peters","year":"1992","journal-title":"Development"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0965","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ydbio.2016.03.026","article-title":"FGFR2c-mediated ERK-MAPK activity regulates coronal suture development","volume":"415","author":"Pfaff","year":"2016","journal-title":"Developmental Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0970","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/jcp.20620","article-title":"Downregulation of Akt activity contributes to the growth arrest induced by FGF in chondrocytes","volume":"207","author":"Priore","year":"2006","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0975","doi-asserted-by":"crossref","first-page":"18297","DOI":"10.1073\/pnas.0908836106","article-title":"Temporomandibular joint formation requires two distinct hedgehog-dependent steps","volume":"106","author":"Purcell","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0980","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.bbamcr.2014.03.011","article-title":"FGFR3 induces degradation of BMP type I receptor to regulate skeletal development","volume":"1843","author":"Qi","year":"2014","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0985","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1172\/JCI38017","article-title":"Antibody-based targeting of FGFR3 in bladder carcinoma and t(4,14)-positive multiple myeloma in mice","volume":"119","author":"Qing","year":"2009","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0990","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000202789","article-title":"Differential FGF ligands and FGF receptors expression pattern in frontal and parietal calvarial bones","volume":"190","author":"Quarto","year":"2009","journal-title":"Cells, Tissues, Organs"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb0995","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1074\/jbc.M310384200","article-title":"Activation of the ERK1\/2 and p38 mitogen-activated protein kinase pathways mediates fibroblast growth factor-induced growth arrest of chondrocytes","volume":"279","author":"Raucci","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1000","doi-asserted-by":"crossref","first-page":"38194","DOI":"10.1074\/jbc.M303164200","article-title":"Human combinatorial Fab library yielding specific and functional antibodies against the human fibroblast growth factor receptor 3","volume":"278","author":"Rauchenberger","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1005","doi-asserted-by":"crossref","first-page":"38209","DOI":"10.1074\/jbc.M404855200","article-title":"FGF18 represses noggin expression and is induced by calcineurin","volume":"279","author":"Reinhold","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1010","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1074\/jbc.M608995200","article-title":"Direct interactions of Runx2 and canonical Wnt signaling induce FGF18","volume":"282","author":"Reinhold","year":"2007","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1015","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1242\/dev.127.9.1845","article-title":"Integration of FGF and TWIST in calvarial bone and suture development","volume":"127","author":"Rice","year":"2000","journal-title":"Development"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S8756-3282(03)00163-7","article-title":"Fgfr mRNA isoforms in craniofacial bone development","volume":"33","author":"Rice","year":"2003","journal-title":"Bone"},{"issue":"367 Suppl.","key":"10.1016\/bs.ctdb.2018.11.020_bb1025","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1097\/00003086-199910001-00018","article-title":"Fibroblast growth factor receptor-3 as a marker for precartilaginous stem cells","author":"Robinson","year":"1999","journal-title":"Clinical Orthopaedics and Related Research"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/371252a0","article-title":"Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia","volume":"371","author":"Rousseau","year":"1994","journal-title":"Nature"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1035","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1210\/en.2013-1025","article-title":"BMP-2 differentially modulates FGF-2 isoform effects in osteoblasts from newborn transgenic mice","volume":"154","author":"Sabbieti","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1040","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jcp.21661","article-title":"Endogenous FGF-2 is critically important in PTH anabolic effects on bone","volume":"219","author":"Sabbieti","year":"2009","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1045","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/jcb.25014","article-title":"Mutation of Spry2 induces proliferation and differentiation of osteoblasts but inhibits proliferation of gingival epithelial cells","volume":"116","author":"Sanui","year":"2015","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1050","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/bjc.2014.638","article-title":"mTOR inhibition improves fibroblast growth factor receptor targeting in hepatocellular carcinoma","volume":"112","author":"Scheller","year":"2015","journal-title":"British Journal of Cancer"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1055","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1082024","article-title":"Signal transduction. Autoinhibition control","volume":"300","author":"Schlessinger","year":"2003","journal-title":"Science"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1060","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/hmg\/9.2.249","article-title":"Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice","volume":"9","author":"Segev","year":"2000","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1065","doi-asserted-by":"crossref","first-page":"41862","DOI":"10.1074\/jbc.M308336200","article-title":"Mouse Snail family transcription repressors regulate chondrocyte, extracellular matrix, type II collagen, and aggrecan","volume":"278","author":"Seki","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4161\/org.23307","article-title":"Craniosynostosis: Molecular pathways and future pharmacologic therapy","volume":"8","author":"Senarath-Yapa","year":"2012","journal-title":"Organogenesis"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1075","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.217","article-title":"E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis","volume":"4","author":"Severe","year":"2013","journal-title":"Cell Death & Disease"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1080","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41598-017-18801-0","article-title":"Skeletal characterization of the Fgfr3 mouse model of Achondroplasia using micro-CT and MRI volumetric imaging","volume":"8","author":"Shazeeb","year":"2018","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1085","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1387\/ijdb.092887cs","article-title":"Comprehensive analysis of fibroblast growth factor receptor expression patterns during chick forelimb development","volume":"54","author":"Sheeba","year":"2010","journal-title":"The International Journal of Developmental Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1090","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0092-8674(94)90302-6","article-title":"Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia","volume":"78","author":"Shiang","year":"1994","journal-title":"Cell"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.devcel.2011.06.027","article-title":"Cell surface heparan sulfate chains regulate local reception of FGF signaling in the mouse embryo","volume":"21","author":"Shimokawa","year":"2011","journal-title":"Developmental Cell"},{"issue":"22","key":"10.1016\/bs.ctdb.2018.11.020_bb1100","first-page":"3827","article-title":"PIN1 is a new therapeutic target of craniosynostosis","volume":"27","author":"Shin","year":"2018","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1105","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/ng2096","article-title":"RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis","volume":"39","author":"Shukla","year":"2007","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1110","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1093\/hmg\/dds305","article-title":"Disruption of a Sox9-beta-catenin circuit by mutant Fgfr3 in thanatophoric dysplasia type II","volume":"21","author":"Shung","year":"2012","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104987","article-title":"Snail promotes epithelial mesenchymal transition in breast cancer cells in part via activation of nuclear ERK2","volume":"9","author":"Smith","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1120","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.2527\/jas.2006-255","article-title":"Enhanced skeletal growth of sheep heterozygous for an inactivated fibroblast growth factor receptor 3","volume":"84","author":"Smith","year":"2006","journal-title":"Journal of Animal Science"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1125","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/jcb.21068","article-title":"Regulated expression of syndecan-4 in rat calvaria osteoblasts induced by fibroblast growth factor-2","volume":"100","author":"Song","year":"2007","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1130","doi-asserted-by":"crossref","DOI":"10.1038\/boneres.2014.3","article-title":"Role of FGF\/FGFR signaling in skeletal development and homeostasis: Learning from mouse models","volume":"2","author":"Su","year":"2014","journal-title":"Bone Research"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1135","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/386288a0","article-title":"Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism","volume":"386","author":"Su","year":"1997","journal-title":"Nature"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1140","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/hmg\/ddp590","article-title":"Gain-of-function mutation in FGFR3 in mice leads to decreased bone mass by affecting both osteoblastogenesis and osteoclastogenesis","volume":"19","author":"Su","year":"2010","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1145","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/75644","article-title":"Conditional inactivation of Fgf4 reveals complexity of signalling during limb bud development","volume":"25","author":"Sun","year":"2000","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1150","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1002\/jcp.24021","article-title":"Apert syndrome mutant FGFR2 and its soluble form reciprocally alter osteogenesis of primary calvarial osteoblasts","volume":"227","author":"Suzuki","year":"2012","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1155","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/aja.1002040410","article-title":"Changes in the expression of fibroblast growth factor receptors mark distinct stages of chondrogenesis in vitro and during chick limb skeletal patterning","volume":"204","author":"Szebenyi","year":"1995","journal-title":"Developmental Dynamics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1160","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1101\/gad.1547407","article-title":"Rethinking the proximodistal axis of the vertebrate limb in the molecular era","volume":"21","author":"Tabin","year":"2007","journal-title":"Genes & Development"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1165","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1002\/j.1460-2075.1996.tb00840.x","article-title":"FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2","volume":"15","author":"Tan","year":"1996","journal-title":"The EMBO Journal"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1170","doi-asserted-by":"crossref","first-page":"45926","DOI":"10.1074\/jbc.M404824200","article-title":"A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome","volume":"279","author":"Tanimoto","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1175","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1086\/302275","article-title":"A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene","volume":"64","author":"Tavormina","year":"1999","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1180","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng0395-321","article-title":"Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3","volume":"9","author":"Tavormina","year":"1995","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1185","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1242\/dev.023176","article-title":"Wnt and FGF signals interact to coordinate growth with cell fate specification during limb development","volume":"135","author":"Ten Berge","year":"2008","journal-title":"Development"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1190","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/jcb.22108","article-title":"The osteogenic transcription factor Runx2 regulates components of the fibroblast growth factor\/proteoglycan signaling axis in osteoblasts","volume":"107","author":"Teplyuk","year":"2009","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1195","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nsmb.2752","article-title":"Competition between Grb2 and Plcgamma1 for FGFR2 regulates basal phospholipase activity and invasion","volume":"21","author":"Timsah","year":"2014","journal-title":"Nature Structural & Molecular Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1200","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.devcel.2004.05.019","article-title":"Sef is a spatial regulator for Ras\/MAP kinase signaling","volume":"7","author":"Torii","year":"2004","journal-title":"Developmental Cell"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1205","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1086\/508433","article-title":"A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome","volume":"79","author":"Toydemir","year":"2006","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1210","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1182\/blood-2004-10-3913","article-title":"CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4,14) multiple myeloma","volume":"105","author":"Trudel","year":"2005","journal-title":"Blood"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1215","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1182\/blood-2005-10-4179","article-title":"The inhibitory anti-FGFR3 antibody, PRO-001, is cytotoxic to t(4;14) multiple myeloma cells","volume":"107","author":"Trudel","year":"2006","journal-title":"Blood"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1220","doi-asserted-by":"crossref","DOI":"10.1126\/stke.2282004pe17","article-title":"Promotion and attenuation of FGF signaling through the Ras-MAPK pathway","volume":"2004","author":"Tsang","year":"2004","journal-title":"Science's STKE"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1225","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: From development to cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1230","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/dvdy.21790","article-title":"Skeletal analysis of the Fgfr3(P244R) mouse, a genetic model for the Muenke craniosynostosis syndrome","volume":"238","author":"Twigg","year":"2009","journal-title":"Developmental Dynamics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1235","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ng.2539","article-title":"Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1\/2 signaling to regulation of osteogenesis","volume":"45","author":"Twigg","year":"2013","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1240","first-page":"23","article-title":"The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: The achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans","volume":"21","author":"Vajo","year":"2000","journal-title":"Endocrine Reviews"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1245","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/hmg\/ddh034","article-title":"Defective bone mineralization and osteopenia in young adult FGFR3-\/-mice","volume":"13","author":"Valverde-Franco","year":"2004","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1250","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1073\/pnas.96.8.4455","article-title":"A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3","volume":"96","author":"Wang","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1255","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-213X-10-22","article-title":"Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2(+P253R) mice","volume":"10","author":"Wang","year":"2010","journal-title":"BMC Developmental Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1260","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1242\/dev.01914","article-title":"Abnormalities in cartilage and bone development in the Apert syndrome FGFR2(+\/S252W) mouse","volume":"132","author":"Wang","year":"2005","journal-title":"Development"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1265","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nature01545","article-title":"The BMP antagonist noggin regulates cranial suture fusion","volume":"422","author":"Warren","year":"2003","journal-title":"Nature"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1270","doi-asserted-by":"crossref","first-page":"24912","DOI":"10.1074\/jbc.M116.730093","article-title":"Chondrocyte FGFR3 regulates bone mass by inhibiting osteogenesis","volume":"291","author":"Wen","year":"2016","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1275","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1124\/jpet.114.218560","article-title":"Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfism","volume":"353","author":"Wendt","year":"2015","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1280","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1002\/art.34645","article-title":"Genetic inhibition of fibroblast growth factor receptor 1 in knee cartilage attenuates the degeneration of articular cartilage in adult mice","volume":"64","author":"Weng","year":"2012","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1285","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cytogfr.2005.03.001","article-title":"Bad bones, absent smell, selfish testes: The pleiotropic consequences of human FGF receptor mutations","volume":"16","author":"Wilkie","year":"2005","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1290","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/ng0907-1057","article-title":"Cancer drugs to treat birth defects","volume":"39","author":"Wilkie","year":"2007","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1295","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/302000","article-title":"Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome","volume":"63","author":"Wilkin","year":"1998","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1300","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/jbmr.1810","article-title":"Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets","volume":"28","author":"Wohrle","year":"2013","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077652","article-title":"Fibroblast growth factor receptors as novel therapeutic targets in SNF5-deleted malignant rhabdoid tumors","volume":"8","author":"Wohrle","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1310","article-title":"Antibody-mediated activation of FGFR1 induces FGF23 production and hypophosphatemia","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1315","doi-asserted-by":"crossref","first-page":"17121","DOI":"10.1074\/jbc.M212590200","article-title":"The involvement of heparan sulfate (HS) in FGF1\/HS\/FGFR1 signaling complex","volume":"278","author":"Wu","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1320","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1210\/en.2016-1617","article-title":"Inhibition of FGFR signaling partially rescues hypophosphatemic rickets in HMWFGF2 Tg male mice","volume":"158","author":"Xiao","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1325","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jbmr.1721","article-title":"Nuclear fibroblast growth factor 2 (FGF2) isoforms inhibit bone marrow stromal cell mineralization through FGF23\/FGFR\/MAPK in vitro","volume":"28","author":"Xiao","year":"2013","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1330","article-title":"Osteocyte-specific deletion of Fgfr1 suppresses FGF23","volume":"9","author":"Xiao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1335","doi-asserted-by":"crossref","first-page":"36181","DOI":"10.1074\/jbc.M206057200","article-title":"Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1\/Runx2","volume":"277","author":"Xiao","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1340","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1074\/jbc.M804900200","article-title":"Exported 18-kDa isoform of fibroblast growth factor-2 is a critical determinant of bone mass in mice","volume":"284","author":"Xiao","year":"2009","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1345","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1074\/jbc.M109.030577","article-title":"Nuclear isoforms of fibroblast growth factor 2 are novel inducers of hypophosphatemia via modulation of FGF23 and KLOTHO","volume":"285","author":"Xiao","year":"2010","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1350","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.bone.2010.05.021","article-title":"Disruption of the Fgf2 gene activates the adipogenic and suppresses the osteogenic program in mesenchymal marrow stromal stem cells","volume":"47","author":"Xiao","year":"2010","journal-title":"Bone"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1355","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-biochem-060713-035314","article-title":"Demystifying heparan sulfate-protein interactions","volume":"83","author":"Xu","year":"2014","journal-title":"Annual Review of Biochemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1360","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0925-4773(99)00034-9","article-title":"Genomic structure, mapping, activity and expression of fibroblast growth factor 17","volume":"83","author":"Xu","year":"1999","journal-title":"Mechanisms of Development"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1365","doi-asserted-by":"crossref","DOI":"10.1186\/ar3441","article-title":"Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytes","volume":"13","author":"Yan","year":"2011","journal-title":"Arthritis Research & Therapy"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1370","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bone.2008.02.008","article-title":"The study of abnormal bone development in the Apert syndrome Fgfr2+\/S252W mouse using a 3D hydrogel culture model","volume":"43","author":"Yang","year":"2008","journal-title":"Bone"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1375","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1210\/en.2008-1676","article-title":"Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias","volume":"150","author":"Yasoda","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1380","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nm971","article-title":"Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway","volume":"10","author":"Yasoda","year":"2004","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1385","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s12015-011-9327-6","article-title":"FGFR2 mutation confers a less drastic gain of function in mesenchymal stem cells than in fibroblasts","volume":"8","author":"Yeh","year":"2012","journal-title":"Stem Cell Reviews"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1390","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bone.2007.11.019","article-title":"A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis","volume":"42","author":"Yin","year":"2008","journal-title":"Bone"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1395","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1242\/dmm.024760","article-title":"Inhibition of fibroblast growth factor receptor 3-dependent lung adenocarcinoma with a human monoclonal antibody","volume":"9","author":"Yin","year":"2016","journal-title":"Disease Models & Mechanisms"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1400","doi-asserted-by":"crossref","first-page":"8828","DOI":"10.1074\/jbc.M113.516237","article-title":"Prolyl isomerase Pin1-mediated conformational change and subnuclear focal accumulation of Runx2 are crucial for fibroblast growth factor 2 (FGF2)-induced osteoblast differentiation","volume":"289","author":"Yoon","year":"2014","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1405","doi-asserted-by":"crossref","first-page":"14536","DOI":"10.1073\/pnas.97.26.14536","article-title":"Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome","volume":"97","author":"Yu","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1410","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1073\/pnas.081082498","article-title":"Uncoupling fibroblast growth factor receptor 2 ligand binding specificity leads to Apert syndrome-like phenotypes","volume":"98","author":"Yu","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1415","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1242\/dev.013268","article-title":"FGF signaling regulates mesenchymal differentiation and skeletal patterning along the limb bud proximodistal axis","volume":"135","author":"Yu","year":"2008","journal-title":"Development"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1420","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1242\/dev.00491","article-title":"Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth","volume":"130","author":"Yu","year":"2003","journal-title":"Development"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1425","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ncb2743","article-title":"The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis","volume":"15","author":"Zhang","year":"2013","journal-title":"Nature Cell Biology"},{"key":"10.1016\/bs.ctdb.2018.11.020_bb1430","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/hmg\/9.13.2001","article-title":"A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures","volume":"9","author":"Zhou","year":"2000","journal-title":"Human Molecular Genetics"}],"container-title":["Current Topics in Developmental Biology","Vertebrate Skeletal Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0070215318300991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0070215318300991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T17:54:54Z","timestamp":1662746094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0070215318300991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9780128104873"],"references-count":285,"URL":"https:\/\/doi.org\/10.1016\/bs.ctdb.2018.11.020","relation":{},"ISSN":["0070-2153"],"issn-type":[{"value":"0070-2153","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}